stockrow
Friday 6 November 2026
Export STAA’s income statement to Excel — free account
STAAR Surgical Company
STAA Healthcare Medical Instruments & Supplies
STAAR Surgical Company’s revenue for fiscal 2025 (year ended December 2025) was $239.4 million, down 23.7% from fiscal 2024.
- Revenue
- −12.0%
- EPS
- −38.9%
- Free cash flow
- +1,378.7%
Quarter to September 2026, against a year earlier
25.44
1.28
−4.79%
Follow STAA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(21.70%) | (5.99%) | 1.09% | 0.15% | |
Piotroski F-Score |
1 | 4 | 5 | 6 | |
| (16.74%) | (4.63%) | 0.84% | 0.11% | ||
ROIC |
(30.31%) | (7.49%) | 4.67% | 0.26% | |
Return on Tangible Assets |
(25.43%) | (6.51%) | 1.13% | 0.15% | |
Average Days of Receivables |
76.32 | 102.03 | 105.84 | 96.21 | |
Free Cash Flow per Share |
(0.81) | (1.10) | (0.13) | 0.35 | |
Free Cash Flow |
(40.05) | (54.99) | (6.75) | 17.85 | |
Capital Expenditures |
(5.82) | (4.79) | (3.50) | (3.55) | |
| Other line items | |||||
Cash ROIC |
(7.10%) | (10.04%) | (1.23%) | 3.06% | |
Accounts Receivable Turnover |
3.74 | 4.79 | 5.11 | 4.48 | |
Accounts Payable Turnover |
4.03 | 6.66 | 6.15 | 7.41 | |
Inventory Turnover |
1.15 | 1.37 | 1.59 | 1.77 | |
Average Days of Payables |
74.09 | 47.30 | 61.96 | 59.91 | |
Days of Inventory on Hand |
355.23 | 270.80 | 215.34 | 189.28 | |
Tax Rate |
(0.02) | 0.08 | (0.78) | (0.90) | |
Research and Development Expense of Revenue |
16.73% | 13.31% | 11.28% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
78.65% | 61.45% | 53.26% | 0.00% | |
Share Based Compensation of Revenue |
12.77% | 10.12% | 8.29% | 7.77% | |
Operating CF/Net income |
0.43 | 2.39 | (0.85) | 40.37 | |
Depreciation/Fixed assets |
0.12 | 0.12 | 0.14 | 0.00 | |
Capex/Depreciation |
(0.68) | (0.58) | (0.37) | 0.00 | |
Revenue per Share |
4.83 | 5.82 | 6.75 | 6.50 | |
Operating CF per Share |
(0.69) | (1.01) | (0.06) | 0.42 | |
Capex per Share |
(0.12) | (0.10) | (0.07) | (0.07) | |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 4 Nov 2026